EXPONENT INC EXPO

Industrials SIC 8742 - Services-Management Consulting Services NAICS Professional, Scientific, and Technical Services › Management, Scientific, and Technical Consulting Services › Management Consulting Services › Administrative Management and General Management Consulting Services derived Nasdaq

Exponent, Inc., together with its subsidiaries, ("Exponent", the "Company", "we", "us" and "our") is a science and engineering consulting firm that provides solutions to complex problems. Our interdisciplinary team of scientists, physicians, engineers, and business consultants draws from more than 90 technical disciplines to solve the most pressing and complicated challenges facing stakeholders today. The firm leverages over 55 years of experience in analyzing accidents and failures to advise clients as they innovate their technologically complex products and processes, ensure the safety and health of their users, and address the challenges of sustainability.

The history of Exponent, Inc. goes back to 1967, with the founding of the partnership Failure Analysis Associates, which was incorporated the following year in California and reincorporated in Delaware as Failure Analysis Associates, Inc. in 1988. The Failure Group, Inc. was organized in 1989 as a holding company for Failure Analysis Associates, Inc. and changed its name to Exponent, Inc. in 1998.

Last close 77.43 2026-10-23
Market cap $3.68B 2026-07-03 share count
52-week range 51.91 - 81.95

Valuation FY2025 figures against the last close

P/S6.3x
P/E37.4x
P/FCF30.1x
EV/EBITDA30.7x
Dividend yield1.6%
Diluted EPS2.07

Where the revenue comes from as reported in the latest 10-K

Revenue by segment

  • Engineering and Other Scientific
  • Environmental and Health
Revenue by segment, 2 categories over 3 years. The same figures are in the table below. FY2025 Engineering and Other Scientific, FY2025: 493.9M (84.9%) 85% Engineering and Other Scientific Environmental and Health, FY2025: 88.1M (15.1%) 15% FY2024 Engineering and Other Scientific, FY2024: 469.5M (84.1%) 84% Environmental and Health, FY2024: 89M (15.9%) 16% FY2023 Engineering and Other Scientific, FY2023: 446.9M (83.3%) 83% Environmental and Health, FY2023: 89.9M (16.7%) 17%
Segment FY2025FY2024FY2023
Engineering and Other Scientific $493.9M $469.5M $446.9M
Environmental and Health $88.1M $89.0M $89.9M

As the company reported it, from the “Segment Information (Detail)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Segments are the filer's own reporting structure, which is a decision about how it runs itself rather than a standard taxonomy: two companies in the same industry routinely divide themselves along different lines, so these are worth reading down a single company rather than across two. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $582.0M$558.5M$536.8M$513.3M$466.3M$399.9M$417.2M$379.5M$347.8M$315.1M
SG&A $25.5M$22.7M$24.4M$23.7M$15.3M$12.9M$20.5M$17.5M$17.8M$15.5M
Total operating expenses $462.2M$439.0M$425.4M$372.5M$357.3M$316.7M$332.1M$288.1M$275.7M$253.2M
Operating income $119.8M$119.6M$111.3M$140.8M$108.9M$83.2M$85.1M$91.5M$72.1M$61.9M
Pre-tax income $147.3M$147.4M$135.9M$132.2M$125.8M$96.9M$104.2M$93.3M$82.5M$69.1M
Income tax $41.3M$38.4M$35.6M$29.9M$24.6M$14.4M$21.7M$21.1M$41.2M$21.6M
Net income $106.0M$109.0M$100.3M$102.3M$101.2M$82.6M$82.5M$72.3M$41.3M$47.5M
EPS, basic 2.082.131.961.981.921.581.561.370.780.90
EPS, diluted 2.072.111.941.961.901.551.531.330.770.87
Shares, diluted (wtd. avg.) 51.2M51.6M51.6M52.3M53.3M53.3M53.9M54.2M54.0M54.3M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $221.9M$258.9M$187.2M$161.5M$297.7M$197.5M$176.4M$127.1M$124.8M$115.0M
Short-term investments —————$45.0M$55.2M$81.5M$71.6M$58.8M
Receivables $181.5M$161.4M$167.4M$170.1M$139.9M$111.6M$120.1M$105.8M$110.1M$87.4M
Total current assets $427.6M$446.9M$379.5M$349.2M$452.8M$366.8M$364.0M$326.6M$315.5M$274.0M
Property, plant and equipment $72.0M$73.0M$75.3M$65.5M$60.0M$59.8M$61.6M$46.1M$35.0M$36.7M
Goodwill $8.6M$8.6M$8.6M$8.6M$8.6M$8.6M$8.6M$8.6M$8.6M$8.6M
Total assets $777.5M$777.3M$646.8M$586.7M$683.7M$580.1M$563.4M$468.9M$439.6M$403.7M
Accounts payable $6.9M$5.3M$4.5M$8.6M$3.2M$3.3M$4.6M$2.6M$2.8M$3.2M
Total current liabilities $178.0M$163.2M$161.9M$159.0M$153.0M$117.3M$124.0M$98.3M$93.1M$80.2M
Total liabilities $387.2M$356.2M$290.7M$265.9M$266.7M$218.6M$213.2M$155.0M$150.5M$130.4M
Retained earnings $668.4M$624.2M$574.1M$528.8M$478.4M$421.8M$384.7M$342.0M$304.0M$291.2M
Total equity $390.3M$421.1M$356.1M$320.8M$417.1M$361.5M$350.3M$313.9M$289.1M$273.3M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $131.7M$144.5M$127.4M$93.8M$124.6M$103.3M$108.1M$91.2M$67.8M$66.9M
Stock-based compensation $23.8M$23.2M$20.4M$20.4M$19.3M$17.3M$17.5M$17.0M$16.2M$13.3M
Capital expenditure $9.4M$6.9M$16.4M$12.0M$6.8M$5.0M$23.0M$16.3M$4.7M$14.4M
Investing cash flow -$9.4M-$6.9M-$16.4M-$12.0M$38.2M$5.0M$4.3M-$25.8M-$17.7M-$27.4M
Financing cash flow -$160.4M-$65.1M-$86.0M-$216.0M-$62.8M-$88.4M-$63.4M-$62.5M-$41.3M-$49.2M
Dividends paid $60.4M$56.8M$54.0M$49.2M$43.2M$39.8M$33.5M$27.2M$21.8M$18.8M
Buybacks $97.1M$5.7M$24.2M$155.9M$7.0M$40.0M$22.0M$27.9M$11.9M$24.5M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-163945.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 200M 400M 600M Revenue, FY2016: 315.1M Net income, FY2016: 47.5M Revenue, FY2017: 347.8M Net income, FY2017: 41.3M Revenue, FY2018: 379.5M Net income, FY2018: 72.3M Revenue, FY2019: 417.2M Net income, FY2019: 82.5M Revenue, FY2020: 399.9M Net income, FY2020: 82.6M Revenue, FY2021: 466.3M Net income, FY2021: 101.2M Revenue, FY2022: 513.3M Net income, FY2022: 102.3M Revenue, FY2023: 536.8M Net income, FY2023: 100.3M Revenue, FY2024: 558.5M Net income, FY2024: 109M Revenue, FY2025: 582M Net income, FY2025: 106M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $315.1M $347.8M $379.5M $417.2M $399.9M $466.3M $513.3M $536.8M $558.5M $582.0M
Gross profit — — — — — — — — — —
Net income $47.5M $41.3M $72.3M $82.5M $82.6M $101.2M $102.3M $100.3M $109.0M $106.0M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Results announced Item 2.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 8742

TickerCompanyMarket capP/ERevenue growth
BAH Booz Allen Hamilton Holding Corp $9.42B 11.4x -6.4%
G Genpact LTD $6.86B 13.0x 6.6%
FCN FTI CONSULTING, INC $4.34B 19.1x 2.4%
HURN Huron Consulting Group Inc. $3.17B 33.5x 11.9%
ASTH Astrana Health, Inc. $2.09B 81.4x 56.4%
ICFI ICF International, Inc. $1.69B 19.1x -7.3%
BWMN Bowman Consulting Group Ltd. $742.5M 58.7x 14.9%
ONT Onterris, Inc. $520.8M — 19.3%